GT Biopharma, Inc. Contracts & Agreements

194 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AGREEMENT
GT Biopharma, Inc.
Biotechnology
2008
Investigator Initiated Clinical Trial Agreement, dated as of November 18, 2024, by and between GT Biopharma, Inc. and the Regents of the University of Minnesota
GT Biopharma, Inc.
2024
Amended and Restated Exclusive Patent License Agreement with the Regents of the University of Minnesota, dated May 13, 2024
License Agreements
GT Biopharma, Inc.
2024
Sponsored Research Agreement with the Regents of the University of Minnesota dated May 20, 2024
GT Biopharma, Inc.
2024
Employment Agreement between the Company and Alan Urban, dated as of June 7, 2024
Employment Agreements
GT Biopharma, Inc.
2024
Form of Common Warrant
Warrant Agreements
GT Biopharma, Inc.
2024
Form of Securities Purchase Agreement, dated May 21, 2024
Purchase Agreements
GT Biopharma, Inc.
2024
Form of Placement Agency Agreement, dated May 21, 2024
Agency Agreements
GT Biopharma, Inc.
2024
Amendment No. 1 to Settlement and Investment Agreement, dated as of April 25, 2024, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc
Settlement Agreements
GT Biopharma, Inc.
2024
Amendment No. 1 to Employment Agreement with Michael Breen, dated as of June 17, 2022
Employment Agreements
GT Biopharma, Inc.
2024
Amendment No. 2 to Services Agreement with Michael Breen, dated as of February 20, 2023
Services Agreements
GT Biopharma, Inc.
2024
Amendment No. 1 to Employment Agreement with Manu Ohri, dated as of February 17, 2023
Employment Agreements
GT Biopharma, Inc.
2024
Description of the Registrants Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
GT Biopharma, Inc.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
GT Biopharma, Inc.
2023
Form of Pre-Funded Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Form of Placement Agent Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Form of Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
2023
Settlement and Investment Agreement dated August 24, 2022, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc
Settlement Agreements
GT Biopharma, Inc.
2022
Board Service Agreement with Michael Breen dated November 11, 2020
Services Agreements
GT Biopharma, Inc.
2022
Employment Agreement with Manu Ohri dated May 15, 2022
Employment Agreements
GT Biopharma, Inc.
2022
Exclusive License Agreement with Regents of the University of Minnesota, dated March 26, 2021
License Agreements
GT Biopharma, Inc.
Biotechnology
2022
Research Agreement with Regents of the University of Minnesota, dated June 16, 2021
GT Biopharma, Inc.
2022
Sublease Agreement dated November, 2021, between Aimmune Therapeutics, Inc. (Sublandlord) and GT Biopharma, Inc. (Subtenant)
Lease Agreements
GT Biopharma, Inc.
2022
Employment Agreement with Michael Breen, entered into as of December 31, 2021 with an effective date of November 8, 2021
Employment Agreements
GT Biopharma, Inc.
2022
Amended and Restated Employment Agreement with Anthony Cataldo, dated April 23, 2021
Employment Agreements
GT Biopharma, Inc.
2021
Amended and Restated Employment Agreement with Michael Handelman, dated April 23, 2021
Employment Agreements
GT Biopharma, Inc.
2021
Amended and Restated Employment Agreement with Dr. Gregory Berk, dated April 23, 2021
Employment Agreements
GT Biopharma, Inc.
Biotechnology
MA
2021
Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc., dated April 3, 2019
Stock Agreements
GT Biopharma, Inc.
2021
Amendment to Convertible Note, effective as of January 31, 2021, by and between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Note Agreements
GT Biopharma, Inc.
2021
Form of Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of December 2020 / January 2021 Note
Note Agreements
GT Biopharma, Inc.
2021
Form of Underwriting Agreement
Underwriting Agreements
GT Biopharma, Inc.
2021
Board Service Agreement with Rajesh Shrotriya, dated January 12, 2021
Services Agreements
GT Biopharma, Inc.
Biotechnology
2021
Board Service Agreement with Michael Breen, dated January 12, 2021
Services Agreements
GT Biopharma, Inc.
Biotechnology
2021
Amendment to Settlement Note with Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of Securities Purchase Agreement - December 2020 / January 2021 Notes
Note Agreements
GT Biopharma, Inc.
2021
Form of December 2020 / January 2021 Note
Note Agreements
GT Biopharma, Inc.
2021
Form of Second Amendment and Extension of Standstill and Forbearance Agreement
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of Amendment to Convertible Note, dated as of January 31, 2021
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of Pre-Funded Warrant
Warrant Agreements
GT Biopharma, Inc.
2021
SETTLEMENTAGREEMENT
GT Biopharma, Inc.
Biotechnology
NY
2020
CONVERTIBLE NOTE DUE JANUARY 31, 2021
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
AMENDMENT TO CONVERTIBLE NOTE & STANDSTILLAGREEMENT
Note Agreements
GT Biopharma, Inc.
2020
Settlement Agreement, dated as of November 9, 2020, by and among Adam Kasower, East Ventures, Inc., A British Virgin Islands company, SV Booth Investments III, LLC, a Delaware...
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Settlement Note, dated November 9, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Steve Weldon Letter of Resignation, dated November 11, 2020
GT Biopharma, Inc.
2020
Board Service Agreement with Bruce Wendel, dated November 11, 2020
Services Agreements
GT Biopharma, Inc.
Biotechnology
2020
Board Service Agreement with Greg Berk, dated November 11, 2020
Services Agreements
GT Biopharma, Inc.
Biotechnology
2020
Consultant Agreement with Michael Handelman, dated November 13, 2020
GT Biopharma, Inc.
Biotechnology
DE
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
2020
Master Services Agreement
Services Agreements
GT Biopharma, Inc.
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
2020
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
2020
Employment agreement with Anthony Cataldo
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
Employment agreement with Steven Weldon
Employment Agreements
GT Biopharma, Inc.
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
2020
Registration Rights Agreement
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
STANDSTILL AND FORBEARANCE AGREEMENT
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Settlement Agreement, dated as of June 19, 2020, among GT Biopharma, Inc., Empery Asset Master Ltd., Empery Tax Efficient, LP and Empery Tax Efficient II, LP, Anthony Cataldo and...
Settlement Agreements
GT Biopharma, Inc.
2020
Form of Convertible Note, dated June 19, 2020 (included in Exhibit 10.1)
Note Agreements
GT Biopharma, Inc.
2020
Form of Pre-Funded Warrant to Purchase Common Stock, dated June 19, 2020 (included in Exhibit 10.1)
Warrant Agreements
GT Biopharma, Inc.
2020
Securities Purchase Agreement by and among the Company and the Buyers, dated January 30, 2020
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Registration Rights Agreement by and among the Company and the Buyers, dated January 30, 2020
Registration Rights Agreements
GT Biopharma, Inc.
2020
Form of Note, dated January 30, 2020
Note Agreements
GT Biopharma, Inc.
2020
Securities Purchase Agreement by and among the Company and the Buyers, dated April/May, 2020
Purchase Agreements
GT Biopharma, Inc.
2020
Form of Registration Rights Agreement by and among the Company and the Buyers, dated April/May, 2020
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Note, dated April/May, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Clinical Trial Agreement with University of Minnesota
GT Biopharma, Inc.
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
2019
Registration Rights Agreement
Registration Rights Agreements
GT Biopharma, Inc.
2019
CONVERTIBLE NOTE DUE NOVEMBER ___, 2019
Note Agreements
GT Biopharma, Inc.
2019
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
2019
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
GT Biopharma, Inc.
2019
Form of Secured Convertible Note, dated February 4, 2019
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement by and among the Company and the Purchasers, dated February 4, 2019
Purchase Agreements
GT Biopharma, Inc.
2019
Security Agreement by and among the Company, Alpha Capital Anstalt, as collateral agent, and the Purchasers, dated February 4, 2019
Security Agreements
GT Biopharma, Inc.
2019
Registration Rights Agreement by and among the Company and the Purchasers, dated February 4, 2019
Registration Rights Agreements
GT Biopharma, Inc.
2019
Executive Employment Agreement with Dr. Urbanski
Employment Agreements
GT Biopharma, Inc.
Biotechnology
2018
Form of 10% Senior Convertible Debenture
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and among the Company and the Purchasers, dated September 24, 2018
Purchase Agreements
GT Biopharma, Inc.
2018
Form of 10% Senior Convertible Debenture
Debenture Agreements
GT Biopharma, Inc.
2018
Securities Purchase Agreement by and among the Company and the Purchasers, dated September 7, 2018
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Stock Pledge Agreement
Stock Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Form of 10% Senior Convertible Debenture
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and among the Company and the Purchasers, dated August 2, 2018
Purchase Agreements
GT Biopharma, Inc.
2018
INDEMNIFICATION AGREEMENT
Indemnification Agreements
GT Biopharma, Inc.
Biotechnology
DE
2018
Executive Employment Agreement, dated as of February 15, 2018, between the Company and Cross
Employment Agreements
GT Biopharma, Inc.
2018
First Amendment to the Employment Agreement, dated as of February 14, 2018, between the Company and Dr. Clarence-Smith
Employment Agreements
GT Biopharma, Inc.
2018
Consultant Agreement, dated as of February 14, 2018, between the Company and Mr. Cataldo
GT Biopharma, Inc.
2018
Securities Purchase Agreement by and among the Company and the Buyers, dated January 22, 2018
Purchase Agreements
GT Biopharma, Inc.
2018
Form of Registration Rights Agreement by and among the Company and the Buyers, dated January 22, 2018
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Form of Note
Note Agreements
GT Biopharma, Inc.
2018
Form of Warrant
Warrant Agreements
GT Biopharma, Inc.
2018
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
2017
Agreement and Plan of Merger
Merger Agreements
GT Biopharma, Inc.
2017
Certificate of Designation of Preferences, Rights and Limitations of Series J Convertible Preferred Stock of GT Biopharma, Inc
Stock Agreements
GT Biopharma, Inc.
Biotechnology
2017
Employment Agreement with Anthony Cataldo
Employment Agreements
GT Biopharma, Inc.
2017
Employment Agreement with Dr. Kathleen Clarence-Smith
Employment Agreements
GT Biopharma, Inc.
2017
Employment Agreement with Steven Weldon
Employment Agreements
GT Biopharma, Inc.
2017
EMPLOYMENTAGREEMENT
GT Biopharma, Inc.
Biotechnology
DE
2017
Employment Agreement with Dr. Raymond Urbanski
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Warrant Conversion Agreement
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Preferred Conversion Agreement
GT Biopharma, Inc.
Biotechnology
NY
2017
Amended Note Conversion Agreement
Note Agreements
GT Biopharma, Inc.
2017
Amended Warrant Conversion Agreement
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2017
Amended Preferred Conversion Agreement
GT Biopharma, Inc.
2017
License Agreement with ID4 Pharma LLC
License Agreements
GT Biopharma, Inc.
2017
License Agreement with MultiCell Immunotherapeutics, Inc
License Agreements
GT Biopharma, Inc.
2017
License Agreement with the University of Minnesota
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2017
License Agreement with Daniel A. Vallera, Ph.D
License Agreements
GT Biopharma, Inc.
2017
EXCLUSIVE PATENT LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2017
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
2017
10% SENIOR CONVERTIBLE DEBENTURE DUE JUNE 30, 2017
Debenture Agreements
GT Biopharma, Inc.
2017
COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2017
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
2016
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
EXCLUSIVE PATENT LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2016
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
2016
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
2016
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
EXCLUSIVE PATENT LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
2016
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
2016
LICENSE AGREEMENT
License Agreements
GT Biopharma, Inc.
Biotechnology
2016
NOTE CONVERSION AGREEMENT
Note Agreements
GT Biopharma, Inc.
2016
WARRANT EXERCISE AGREEMENT
Warrant Agreements
GT Biopharma, Inc.
2016
PREFERRED STOCK EXCHANGE AGREEMENT
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
SERIES A WARRANT CERTIFICATE
Warrant Agreements
GT Biopharma, Inc.
2016
CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITAITONS OF SERIES J CONVERTIBLE PREFERRED STOCK OF OXIS INTERNATIONAL, INC.
Stock Agreements
GT Biopharma, Inc.
2016
CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITAITONS OF SERIES J CONVERTIBLE PREFERRED STOCK OF OXIS INTERNATIONAL, INC.
Stock Agreements
GT Biopharma, Inc.
Biotechnology
2016
Employment Agreement of Steven Weldon
Employment Agreements
GT Biopharma, Inc.
2016
Employment Agreement of Anthony Cataldo
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2016
AMENDMENT TO NOTE CONVERSION AGREEMENT
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Note Conversion Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Warrant Exercise Agreement
Warrant Agreements
GT Biopharma, Inc.
2016
Preferred Stock Exchange Agreement
Exchange Agreements
GT Biopharma, Inc.
2016
AMENDED EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
2015
AMENDED EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
10% SENIOR CONVERTIBLE DEBENTURE DUE MARCH______, 2017
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
2015
COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2015
RESEARCH AGREEMENT
GT Biopharma, Inc.
2015
EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
STEVE WELDON EXECUTIVE EMPLOYMENT AGREEMENT AMENDED
Employment Agreements
GT Biopharma, Inc.
Biotechnology
FL
2015
STEVE WELDON EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CO
2014
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2014
10% SENIOR CONVERTIBLE DEBENTURE DUE JULY 24, 2016
Debenture Agreements
GT Biopharma, Inc.
2014
COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2014
SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2012
8.0% TWO-YEAR CONVERTIBLE DEBENTURE
Debenture Agreements
GT Biopharma, Inc.
2012
SERIES A COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2012
SERIES B COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2012
STANDSTILL AND FORBEARANCE AGREEMENT
Forbearance Agreements
GT Biopharma, Inc.
2012
JOINT VENTURE AGREEMENT
Joint Venture Agreements
GT Biopharma, Inc.
2011
OXIS INTERNATIONAL, INC. 2010 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
GT Biopharma, Inc.
2011
SERIES I PREFERRED STOCK PURCHASE AGREEMENT
Stock Agreements
GT Biopharma, Inc.
Biotechnology
DE
2011
FIRST AMENDMENT TO 0% CONVERTIBLE DEBENTURE
Debenture Agreements
GT Biopharma, Inc.
2011
ESCROW AGREEMENT
Escrow Agreements
GT Biopharma, Inc.
Biotechnology
2010
EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
2010
EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
2010
EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2010
EXCHANGEAGREEMENT
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
DE
2010
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
DE
2009
0% CONVERTIBLE DEBENTURE DUE OCTOBER 1, 2011
Debenture Agreements
GT Biopharma, Inc.
2009
Series A COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
2009
Series B COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2009
[OXIS LETTERHEAD]
GT Biopharma, Inc.
Biotechnology
2009
STANDSTILL AND FORBEARANCE AGREEMENT
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
NY
2009
CONVERTIBLE DEMANDPROMISSORY NOTE
Note Agreements
GT Biopharma, Inc.
2009
COMMONSTOCK PURCHASE WARRANT OXISINTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2009
ASSETPURCHASE AGREEMENT
GT Biopharma, Inc.
2008
SECURED PROMISSORYNOTE
GT Biopharma, Inc.
2008
BRISTOL CAPITAL ADVISORS, LLC
GT Biopharma, Inc.
2008
BRISTOLCAPITAL ADVISORS, LLC
GT Biopharma, Inc.
2008
AMENDMENT TO ADVISORY AGREEMENT
Advisory Agreements
GT Biopharma, Inc.
2007
EMPLOYMENT AGREEMENT
Employment Agreements
GT Biopharma, Inc.
2006
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
2006
SECURED CONVERTIBLE DEBENTURE DUE October 25, 2008
Debenture Agreements
GT Biopharma, Inc.
2006
[SERIES A/B/C/D/E] COMMON STOCK PURCHASE WARRANT OXIS INTERNATIONAL, INC.
Warrant Agreements
GT Biopharma, Inc.
2006
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
GT Biopharma, Inc.
2006
SECURITY AGREEMENT
Security Agreements
GT Biopharma, Inc.
2006
RENEWAL AND MODIFICATION PROMISSORY NOTE
Note Agreements
GT Biopharma, Inc.
2006
OXIS INTERNATIONAL INC. COMMON STOCK PURCHASE WARRANT
Warrant Agreements
GT Biopharma, Inc.
2006
AMENDMENT #2 TO EXCLUSIVE LICENSE AND SUPPLY AGREEMENT
License Agreements
GT Biopharma, Inc.
2006
MUTUAL SERVICES AGREEMENT
Services Agreements
GT Biopharma, Inc.
2006
PROMISSORY NOTE
Note Agreements
GT Biopharma, Inc.
2006
PROMISSORY NOTE Foster City, California
Note Agreements
GT Biopharma, Inc.
2006
Standard Form Office Lease between OXIS International, Inc. and Westcore Peninsula Vintage, LLC dated February 2, 2006
Lease Agreements
GT Biopharma, Inc.
2006
Exhibit 10.1
GT Biopharma, Inc.
2005
Exhibit 10.2 STOCK PURCHASE AGREEMENT
Stock Agreements
GT Biopharma, Inc.
2005